Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Current Deferred Revenue: 2022

Historic Current Deferred Revenue for Immunocore Holdings (IMCR) over the last 1 years, with Dec 2022 value amounting to $7.8 million.

  • Immunocore Holdings' Current Deferred Revenue was N/A to $582,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $582,000, marking a year-over-year change of. This contributed to the annual value of $7.8 million for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Immunocore Holdings' Current Deferred Revenue is $7.8 million.
  • Immunocore Holdings' Current Deferred Revenue's 5-year high stood at $7.8 million during FY2022, with a 5-year trough of $7.8 million in FY2022.
  • For the 1-year period, Immunocore Holdings' Current Deferred Revenue averaged around $7.8 million, with its median value being $7.8 million (2022).